Target intelligence / Profile preview

Small nucleolar RNA SNORD83 (SNORD83)

Target
SNORD83
Molecular classification
Small nucleolar RNA (snoRNA), Non-coding RNA, C/D box snoRNA, Small nucleolar ribonucleoprotein complex (component)
01

Overview

Small nucleolar RNA SNORD83 is a member of the C/D box snoRNA family, which are short, non-coding RNAs that guide sequence-specific 2′-O-ribose methylation of target RNAs—primarily ribosomal RNA—during ribosome biogenesis[2][3][4][5]. SNORD83 functions as a recognition scaffold inside nucleolar ribonucleoprotein complexes (snoRNPs), recruiting proteins such as fibrillarin, NOP56, NOP58, and SNU13 to catalyze methylation at specific sites in RNA[2][3][4][5]. It is highly conserved, localized to the nucleolus, and participates in the maturation and stabilization of ribosomes. SNORD83 is not a receptor, enzyme, or drug target, but its proper function is essential for cell viability and protein synthesis through its role in ribosomal RNA processing[2][4][5]. Direct associations with disease or use as a clinical biomarker are not described for SNORD83 as of current literature.

Other names
SNORD83LOC124903098Small nucleolar RNA, C/D box 83
02

Mechanism of action

Not applicable. No drugs currently target SNORD83.

03

Biological functions

Guides site-specific 2′-O-methylation of target RNAs, especially ribosomal RNA (rRNA)Post-transcriptional modification of RNA (primarily rRNA, also snRNA and occasionally mRNA)May participate in pre-rRNA cleavage and processingPotential regulation of alternative splicing (general to snoRNA families, not SNORD83 specifically)
04

Disease associations

Other: General dysregulation of snoRNAs is linked to cancer and ribosome biogenesis defects, but no direct, specific disease association is reported for SNORD83Pathogenic snoRNA mutations can contribute to syndromic conditions, but SNORD83 is not strongly implicated from current literature
05

Safety considerations

None specifically known for SNORD83, as it is not a drug target.Theoretical disruption of snoRNA-guided rRNA modification could impair ribosome function and cell viability
06

Biomarkers

None specific. SnoRNA dysregulation is under study as a broad biomarker class for cancers, but SNORD83 has not been validated as a biomarker

Beyond the preview

Go deeper on Small nucleolar RNA SNORD83 (SNORD83).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD83 (SNORD83).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call